Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 49 (1) , 159-162
- https://doi.org/10.1016/s0015-0282(16)59669-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Decreased ovarian response to human menopausal gonadotropin caused by subcutaneously administered gonadotropin-releasing hormone agonistFertility and Sterility, 1987
- In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone dischargeFertility and Sterility, 1986
- Specific Binding of Gonadotrophin-Releasing Hormone and an Agonist to Human Corpus Luteum Homogenates: Characterization, Properties, and Luteal Phase Levels*Journal of Clinical Endocrinology & Metabolism, 1985
- Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer.Journal of Clinical Oncology, 1985
- Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonistContraception, 1979